| __timestamp | Bio-Techne Corporation | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 79838000 |
| Thursday, January 1, 2015 | 40853000 | 121816000 |
| Friday, January 1, 2016 | 45187000 | 117633000 |
| Sunday, January 1, 2017 | 53514000 | 117456000 |
| Monday, January 1, 2018 | 55329000 | 171984000 |
| Tuesday, January 1, 2019 | 62413000 | 257452000 |
| Wednesday, January 1, 2020 | 65192000 | 477643000 |
| Friday, January 1, 2021 | 70603000 | 540684000 |
| Saturday, January 1, 2022 | 87140000 | 651496000 |
| Sunday, January 1, 2023 | 92493000 | 666563000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, innovation is the key to staying ahead. Bio-Techne Corporation and PTC Therapeutics, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, PTC Therapeutics, Inc. has consistently outpaced Bio-Techne Corporation, with R&D spending growing by over 730%, peaking in 2023. In contrast, Bio-Techne Corporation's R&D expenses increased by approximately 212% during the same period.
While Bio-Techne's R&D investment reached its highest in 2024, PTC Therapeutics' data for that year remains unavailable, leaving room for speculation. This trend highlights the aggressive pursuit of innovation by PTC Therapeutics, Inc., which could be a strategic move to capture a larger market share. As the biotech industry continues to expand, these investments may well determine the future leaders in the field.
R&D Spending Showdown: Eli Lilly and Company vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and PTC Therapeutics, Inc.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and PTC Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc.
Comparing Innovation Spending: PTC Therapeutics, Inc. and Protagonist Therapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: PTC Therapeutics, Inc. and Geron Corporation
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.